Beginners

Mitrade Insights is dedicated to providing investors with rich, timely and most valuable financial information to help investors grasp the market situation and find timely trading opportunities.

2021

Best News & Analysis Provider

FxDailyInfo

2022

Best Forex Educational Resources Global

International Business Magazine

Insights

News

Neurocrine Biosciences: A Smart Biotech Bet With Blockbuster Potential

Source Motley_fool

Explore the exciting world of Neurocrine Biosciences (NASDAQ: NBIX) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
*Stock prices used were the prices of Feb. 19, 2025. The video was published on March 26, 2025.

Should you invest $1,000 in Neurocrine Biosciences right now?

Before you buy stock in Neurocrine Biosciences, consider this:

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Neurocrine Biosciences wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $739,720!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of March 24, 2025

Karl Thiel has no position in any of the stocks mentioned. Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Neurocrine Biosciences. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.

Recommended Articles

US Dollar's Decline Predicted in 2026: Morgan Stanley's Outlook on Currency Volatility Morgan Stanley forecasts a 5% drop in the dollar by mid-2026, attributed to continued Fed rate cuts. A recovery may follow as growth improves and funding currency dynamics shift favorably toward the euro and Swiss franc.

Author Mitrade

Nov 25, Tue

Morgan Stanley forecasts a 5% drop in the dollar by mid-2026, attributed to continued Fed rate cuts. A recovery may follow as growth improves and funding currency dynamics shift favorably toward the euro and Swiss franc.

Asian Markets Steady as Investors Anticipate Fed Rate Cut Amid Internal Debate Asian shares showed mixed performance as investors bet on a likely Federal Reserve rate cut this week. However, tensions within the Fed suggest a contentious meeting, sparking cautious market sentiment.

Author Mitrade

Dec 08, Mon

Asian shares showed mixed performance as investors bet on a likely Federal Reserve rate cut this week. However, tensions within the Fed suggest a contentious meeting, sparking cautious market sentiment.

Gold's Historic 2025 Rally: Can the Momentum Last Through 2026?Following a historic surge in 2025 that saw prices climb over 60% and break records more than 50 times, gold investors are now looking ahead to assess whether the precious metal can sustain its momentum into 2026. Despite outperforming most major asset classes and heading for its best annual performance since 1979, analysts are divided on the outlook—with some seeing further room for gains and others cautioning that risks are rising.

Author Mitrade

Dec 09, Tue

Following a historic surge in 2025 that saw prices climb over 60% and break records more than 50 times, gold investors are now looking ahead to assess whether the precious metal can sustain its momentum into 2026. Despite outperforming most major asset classes and heading for its best annual performance since 1979, analysts are divided on the outlook—with some seeing further room for gains and others cautioning that risks are rising.

Solana Liquidity Crashes to Bear-Market Levels as $500M Liquidation Looms A recent buying spree in Bitcoin lifted major alternative cryptocurrencies, but beneath the surface, Solana is showing signs of stress as liquidity evaporates and market leverage remains dangerously high.

Author Mitrade

21 hours ago

A recent buying spree in Bitcoin lifted major alternative cryptocurrencies, but beneath the surface, Solana is showing signs of stress as liquidity evaporates and market leverage remains dangerously high.

Oracle's Weak Earnings Prompt Concerns Over AI Spending, Pressuring Nvidia and Industry Rivals Oracle's disappointing earnings and soaring expenses have raised fears about AI spending sustainability, causing Nvidia and other related stocks to decline amidst heightened competition and concerns over mounting debt.

Author Mitrade

2 hours ago

Oracle's disappointing earnings and soaring expenses have raised fears about AI spending sustainability, causing Nvidia and other related stocks to decline amidst heightened competition and concerns over mounting debt.

Popular Symbols